[1] 梁后杰,杨晨. 胃肠胰腺神经内分泌肿瘤治疗共识(NCCN、ENETs、NANETs)解读[J]. 临床肿瘤学杂志,2012,16(11): 1039-1043.
[2] Yao JC, Hassan M, Phan A, et al.One Hundred Years After "Carcinoid": Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States[J]. J Clin Oncol, 26(18): 3063-3072.
[3] CSCO神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识[J]. 临床肿瘤学杂志,2018,18(9):815-832.
[4] Raspanti C, Falco N, Silvestri V, et al.Neuroendocrine tumor of the common bile duct: case report[J]. G Chir, 2016, 37(6): 275-280.
[5] Funahashi H, Miyai H, Wakasugi T, et al.Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case[J]. World J Surg Oncol, 2013, 11(1): 263.
[6] Koide N, Suzuki A, Saito H, et al.Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case[J]. Surg Today 2007, 37(11): 989-994. |
